Rezolute TodayRZLTRezolute$7.72 +0.25 (+3.35%) 52-Week Range$2.21▼$8.34Price Target$11.67Add to WatchlistRezolute, Inc.’s NASDAQ: RZLT stock price is steadily moving higher in 2025 and is expected to continue its run because of what adds up to a rapidly improving outlook. Its lead pharmaceutical candidate, Ersodetug, was granted the FDA’s Breakthrough Therapy designation, which puts it on a fast track for approval. The drug is set up for two Phase III trials, which are currently enrolling patients or have ...